Non-muscle Invasive Bladder Cancer Clinical Trials in Nashville, Tennessee

3 studies are recruiting for non-muscle invasive bladder cancer in Nashville, Tennessee right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

    The purpose of this study is to learn how a new medicine called PF-08052667 works when used by itself or together with another medicine called Bacillus Calmette Guerin (BCG), and/or a medicine called sasanlimab. This study is for adults who have a type of bladder cancer that hasn't spread into the …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Urology Associates, P.C., Nashville, Tennessee
    Locations
    68 in total
    Run by
    Pfizer

    See if you can join NCT07206225 on ClinicalTrials.gov

  2. Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

    TARA-002-101-Ph2 is an open-label study to investigate the safety and efficacy of intravesical instillation of TARA-002 in adults 18 years of age or older with high-grade CIS NMIBC (± Ta/T1). The purpose of this Phase 2 study (TARA-002-101-Ph2) is to further assess the safety and efficacy of TARA-0…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Urology Associates PC, Nashville, Tennessee
    Locations
    78 in total
    Run by
    Protara Therapeutics

    See if you can join NCT05951179 on ClinicalTrials.gov

  3. LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

    This study will evaluate the safety and efficacy of intravesical administration of detalimogene (EG-70) in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phases; a Phase 1 dose-escalation to establish safety and recommended the phase 2 dose, fo…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Urology Associates, P.C., Nashville, Tennessee
    Locations
    102 in total
    Run by
    enGene, Inc.

    See if you can join NCT04752722 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.